oleanolic acid has been researched along with gefitinib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, B; Hou, XY; Shi, JJ; Zhang, CL; Zhao, CH; Zhao, LX | 1 |
| Chen, Z; Cheng, YY; Duan, HQ; Goto, M; Huang, KY; Lee, KH; Ling, Y; Liu, YL; Morris-Natschke, SL; Tong, XH; Yang, PC; Yang, SL | 1 |
| Kuai, ZY; Li, W; Liu, LW; Meng, YQ; Zhao, YW | 1 |
3 other study(ies) available for oleanolic acid and gefitinib
| Article | Year |
|---|---|
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pentacyclic Triterpenes; Piperazines; Structure-Activity Relationship | 2015 |
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
Topics: A549 Cells; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Design; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Mutation; Nitric Oxide; Nitric Oxide Donors; Oleanolic Acid; Protein Kinase Inhibitors | 2019 |
Synthesis and antitumor activity evaluation of novel oleanolic acid derivatives.
Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; Gefitinib; HeLa Cells; Humans; Molecular Docking Simulation; Molecular Structure; Oleanolic Acid; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-kit; Quinazolines; Structure-Activity Relationship | 2017 |